ULTIMATE-SHF trial (UdenafiL Therapy to Improve symptoMAtology, exercise Tolerance and hEmodynamics in patients with chronic systolic heart failure): study protocol for a randomized, placebo-controlled, double-blind trial

ULTIMATE-SHF trial (UdenafiL Therapy to Improve symptoMAtology, exercise Tolerance and hEmodynamics in patients with chronic systolic heart failure): study protocol for a randomized, placebo-controlled, double-blind trial

Item

http://www.wikidata.org/entity/Q36958494

Q36958494

about

Advances in pharmacotherapy for erectile dysfunction and associated cardiac impact.Management of pulmonary hypertension from left heart disease in candidates for orthotopic heart transplantation.

P2860

Q38966016-01B00769-139D-4382-8F5C-A811D3014DAF Q41302280-839CC89D-C52E-4F1C-AD6F-3274A6FF0391

P2860

ULTIMATE-SHF trial (UdenafiL Therapy to Improve symptoMAtology, exercise Tolerance and hEmodynamics in patients with chronic systolic heart failure): study protocol for a randomized, placebo-controlled, double-blind trial

Item

http://www.wikidata.org/entity/Q36958494

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

ULTIMATE-SHF trial (UdenafiL T ...... controlled, double-blind trial

@en

type

Item

label

ULTIMATE-SHF trial (UdenafiL T ...... controlled, double-blind trial

@en

prefLabel

ULTIMATE-SHF trial (UdenafiL T ...... controlled, double-blind trial

@en

P1476

ULTIMATE-SHF trial (UdenafiL T ...... controlled, double-blind trial

@en

P2093

Dae-Won Sohn

http://www.w3.org/2001/XMLSchema#string

Hyun-Jae Kang

http://www.w3.org/2001/XMLSchema#string

Hyun-Jai Cho

http://www.w3.org/2001/XMLSchema#string

Hyung-Kwan Kim

http://www.w3.org/2001/XMLSchema#string

In-Chang Hwang

http://www.w3.org/2001/XMLSchema#string

Kyung-Hee Kim

http://www.w3.org/2001/XMLSchema#string

Seung-Pyo Lee

http://www.w3.org/2001/XMLSchema#string

Yong-Jin Kim

http://www.w3.org/2001/XMLSchema#string

P2860

2009 focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: de

Vascular endothelial cells synthesize nitric oxide from L-arginine

Phosphodiesterase type 5 is highly expressed in the hypertrophied human right ventricle, and acute inhibition of phosphodiesterase type 5 improves contractility

Clinical efficacy of sildenafil in primary pulmonary hypertension: a randomized, placebo-controlled, double-blind, crossover study.

Influence of preoperative pulmonary artery pressure on mortality after heart transplantation: testing of potential reversibility of pulmonary hypertension with nitroprusside is useful in defining a high risk group.

Nitric oxide signaling in the cardiovascular system: implications for heart failure.

Udenafil, a long-acting PDE5 inhibitor for erectile dysfunction.

Safety, tolerability and pharmacokinetics of udenafil, a novel PDE-5 inhibitor, in healthy young Korean subjects.

The role of PDE5-inhibitors in cardiopulmonary disorders: from basic evidence to clinical development.

Importance of medication adherence in cardiovascular disease and the value of once-daily treatment regimens.

P2888

1745-6215-14-188

P304

188

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1745-6215-14-188

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-06-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

242015911

http://www.w3.org/2001/XMLSchema#string

P6179

1009023989

http://www.w3.org/2001/XMLSchema#string

P698

23799908

http://www.w3.org/2001/XMLSchema#string

P921

placebo

P932

3694004

http://www.w3.org/2001/XMLSchema#string

ULTIMATE-SHF trial (UdenafiL Therapy to Improve symptoMAtology, exercise Tolerance and hEmodynamics in patients with chronic systolic heart failure): study protocol for a randomized, placebo-controlled, double-blind trial

about

P2860

P2860

ULTIMATE-SHF trial (UdenafiL Therapy to Improve symptoMAtology, exercise Tolerance and hEmodynamics in patients with chronic systolic heart failure): study protocol for a randomized, placebo-controlled, double-blind trial

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P478

P577

P5875

P6179

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P478

P577

P5875

P6179

P698

P921

P932